Vaginal Microbiome in Reproductive Medicine

Area of Science:

• Reproductive Medicine
• Microbiome Research
• Genomics

Background:

• The human microbiome's importance is increasingly recognized, with advanced sequencing identifying numerous bacterial species.
• Reproductive medicine focuses on infertility, particularly implantation failure, and its treatment options.
• The vaginal microbiome is emerging as a key factor in infertility and a potential therapeutic target.

Purpose of the Study:

• To review current research on the vaginal microbiome's influence on reproductive outcomes.
• To explore the link between vaginal microbiome composition and fertility.
• To discuss potential therapeutic strategies targeting the vaginal microbiome.

Main Methods:

• Review of existing scientific literature on vaginal microbiome and reproductive health.
• Analysis of studies correlating microbiome composition with implantation rates and pregnancy success.
• Examination of research on dysbiosis, bacterial vaginosis, and their reproductive implications.

Main Results:

• A vaginal microbiome not dominated by Lactobacillus species is associated with dysbiosis and potentially bacterial vaginosis.
• This imbalance negatively affects implantation rates in assisted reproductive technologies.
• Such imbalances may also contribute to recurrent miscarriages (habitual abortions).

Conclusions:

• Vaginal microbiome screening offers a pathway to identify reproductive health risks.
• Antibiotic and/or probiotic interventions targeting the vaginal microbiome show promise for enhancing pregnancy outcomes.
• Modulating the vaginal microbiome is a potential strategy to improve success rates in reproductive medicine.